HILL-ROM ENVELLA SPECIALTY BEDS RENTAL
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Louis Stokes Veterans Affairs Medical Center (CLE VAMC) in Cleveland, OH, has posted an Award Notice for the rental of Hill-Rom Envella Specialty Beds. This acquisition, valued at up to $781,256.00 over four years, was justified as a limited source acquisition due to the unique and proprietary nature of the Envella Air Fluidized Therapy Beds.
Scope of Work
The contract covers the rental of Envella Air Fluidized Therapy Beds, including the "Day Envella Bed System" and "Day Envella Bed System W/ Trapeze." These specialized beds are essential for patients with complex, advanced wounds such as Stage III/IV pressure injuries, grafts, flaps, burns, and intractable pain, where traditional beds are insufficient. The Envella system is noted for its statistically lower interface pressure, superior microclimate management, and flotation environment, which are critical for wound healing.
Contract & Timeline
- Contractor: Hill-Rom, Inc.
- Type: Firm Fixed Price, Blanket Purchase Agreement (BPA)
- Period of Performance: March 1, 2026, through February 28, 2030 (Base year + three one-year option periods)
- Estimated Dollar Value: $195,314.00 for the base year; $781,256.00 for the base year plus three option years.
- Published Date: February 24, 2026
Justification & Evaluation
This was a limited source acquisition, not a solicitation for proposals. The justification cited GSAR 538.7104-3(b)(1)(ii), indicating that only Hill-Rom/Baxter could provide the unique and highly specialized supplies. Market research, including GSA eLibrary and SBA searches, did not identify other vendors capable of providing equivalent true air-fluidized therapy or comparable clinical performance. A Notice of Intent to Sole Source was posted on SAM.gov, and the single response received was technically reviewed and confirmed to meet minimum needs. The VA and SBA Rule of Two could not be met, and no waiver was applicable.
Additional Notes
The document emphasizes the clinical and technical value, operational efficiency, and cost advantages of the Envella system, noting that alternatives would lead to clinical compromises, increased labor, and potentially longer patient stays. The VA plans to conduct ongoing research to identify new entrants in this product arena for future acquisitions.